Intrinsiqs

Is Black Diamond Therapeutics, Inc. overvalued?

Black Diamond Therapeutics, Inc. (BDTX) — key valuation metrics and fundamentals.

No verdict
Price
$2.02
Fair value
Current P/E
Normal P/E
Market cap
$115.7M
Dividend yield
0.0%
Return on equity
-38.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares BDTX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.